Joshua M. Samek

Partner

Chair, Florida Corporate practice

About

Josh Samek focuses his practice on mergers and acquisitions, capital markets and financing transactions, and general corporate and securities matters, with a particular emphasis on the life sciences, healthcare, and technology sectors. He maintains a nationwide mergers and acquisitions practice representing private equity funds and their portfolio companies, public companies, and founders. Josh also regularly counsels public company boards of directors and executive management on US Securities and Exchange Commission reporting and corporate governance matters.

Areas of FocusFinancial Services Healthcare Insurance Life Sciences Technology Corporate Finance Mergers and Acquisitions Private Equity Public Company Advisory Equity Capital Markets

Bar admissionsDistrict of ColumbiaFlorida

EXPERIENCE

Capital market transactions

An NYSE-listed national medical group in connection in its private offerings of US$1 billion and US$750 million unsecured senior notes under Rule 144A
A NASDAQ‐listed diversified healthcare company in its public offering of US$200 million convertible notes
A NASDAQ-listed women's healthcare company in connection with public offerings and at the market offerings of common stock totaling more than US$650 million
An Israeli biopharmaceutical company in connection with its initial public offering and follow-on offering on the NASDAQ Capital Market
An NYSE-listed REIT in connection with multiple public and private offerings of common stock and secondary offerings of common stock by selling stockholders totaling more than US$650 million
An NYSE-listed REIT in connection with public offerings of US$250 million and US$300 million of senior unsecured notes
The gaming division of a Native American tribe in connection with a US$367 million private offering of taxable and tax-exempt notes
An NYSE-listed diversified specialty contractor in connection with a US$115 million public offering of convertible notes and concurrent secondary offering of common stock by selling shareholders
An institutional investor as selling stockholder in a US$165 million public offering of an NYSE-listed independent oil and natural gas company
Private investors in connection with a PIPE offering in and acquisition of control of an NYSE American-listed developer and marketer of premium spirits

Mergers and acquisitions

A leading FinTech company in its US$800 million business combination with an NYSE-listed special purpose acquisition company
A technology-enabled provider of value-based healthcare in its business combination with a NASDAQ-listed special purpose acquisition company valuing the combined enterprise at US$800 million
An NYSE-listed healthcare company in the divestiture of its radiology and AI-assisted teleradiology business for US$885 million
An NYSE-listed multinational biopharmaceutical and diagnostics company in its US$1.5 billion acquisition of a NASDAQ-listed diagnostic laboratory company
A NASDAQ‐listed multinational biopharmaceutical and diagnostics company in its US$60 million acquisition of a NASDAQ‐listed biopharmaceutical development company
A private-equity backed technology-enabled provider of health system performance optimization solutions in connection with its sale to a new sponsor
A private-equity backed professional employer organization in connection with a management buyout backed by a new sponsor
A private-equity backed business process outsourcing company in connection with its sale to a new sponsor
A leading InsureTech company in connection with its acquisition of a business-to-business insurance agency from a leading global insurance broker and associated debt and equity financing
The special committee of a NASDAQ-listed agricultural company in its review of strategic alternatives

Debt financings

An NYSE-listed national medical group in connection with its US$500 million, US$800 million and US$2.0 billion unsecured revolving credit facilities and US$1.9 billion unsecured revolving credit facility and term loan
A leading FinTech lender in connection with multiple credit facilities, warehouse facilities and other structured financing arrangements
A leading InsureTech company in connection with senior and subordinated credit facilities
A NASDAQ-listed women's healthcare company in connection with US$200 million and US$300 million in senior secured credit facilities
An NYSE-listed REIT in connection with its US$575 million unsecured revolving credit facility and US$250 million unsecured term loan
A privately-held business process outsourcing company in connection with numerous secured revolving credit facilities and term loans

Venture capital/minority investments/joint ventures

A non-profit organization with over US$2 billion in assets in connection with more than 40 venture capital investment transactions
A leading InsureTech company in connection with a highly structured minority investment
A leading InsureTech company in connection with a joint venture and technology licensing transaction
A technology-based education company in connection with capital raising and debt financing transactions

Education

J.D., University of Miami School of Law
Articles and Comments Editor, University of Miami Law Review
summa cum laude
Order of the Coif

B.A., Political Science with a Minor in Economics, University of Michigan

Awards

Seminars

Panelist, BioFlorida 21st Annual Conference (October 2018)
Presenter, Association of Corporate Counsel – Bay Area Chapter Program, Preparing for Proxy Season (November 2017)

Media Mentions

Prior Experience

Office of United States Senator Bill Nelson (D-FL), Washington, DC
Judicial Intern, United States District Judge Ursula Ungaro, Southern District of Florida

Memberships And Affiliations

Member, Advisory Board, National Association of Corporate Directors, Florida Chapter
The Leukemia & Lymphoma Society: Board of Trustees, Southern Florida Chapter, and Past Chair, Florida Advocacy Committee
Member, American Bar Association
Past Member, Greater Miami Jewish Federation Agency Support Committee